STOCK MARKET BSE NSE

COVID-19: 21 hospitals allowed to conduct clinical trials to assess plasma therapy’s efficacy 

In convalescent plasma therapy, a dose of anti-body-containing plasma obtained from the blood of recovered individuals is transfused to persons with the disease to treat it.

Published: 09th May 2020 02:46 AM  |   Last Updated: 09th May 2020 10:17 AM   |  A+A-

A recovered COVID-19 patient who has passed his 14-day quarantine, donates plasma in the city's blood center in Wuhan in central China's Hubei province.

Representational image (EPS | Sunish P Surendran)

By Express News Service

NEW DELHI: Twenty-one hospitals across the country have been granted permission to conduct stage 2 clinical trials to assess the safety and efficacy of convalescent plasma therapy, which has shown some promise in treating moderate to severe COVID-19 cases across the world.

These include five hospitals in Maharashtra; four in Gujarat, two each in Rajasthan, Tamil Nadu, Madhya Pradesh and Uttar Pradesh, and one each in Punjab, Karnataka, Telangana and Chandigarh.

The trials, to be carried out on 452 patients, however, will not have a placebo arm — which means there cannot be a comparison made between two groups of patients for the efficacy of therapy.

“Project PLACID — phase-2 open-label, randomized controlled trial of convalescent plasma by ICMR has received the approval of COVID-19 national ethics committee,” said Lav Agarwal, joint secretary, the health ministry in a briefing on COVID-19 status in the country on Friday.

In convalescent plasma therapy, a dose of anti-body-containing plasma obtained from the blood of recovered individuals is transfused to persons with the disease to treat it.

It’s an experimental therapy, going back a hundred years, has found useful in many diseases and conditions.

It was tested in case of viral outbreaks during the treatment of the infamous 1918 Spanish flu as well as, more recently, during the 2009 H1N1 influenza, SARS and MERS virus outbreaks.

The Central Drug Controller of India had last month finalised protocol for the therapy saying that those recovered can donate blood after 28 days of recovery and cannot be asked to donate more than 1,000 ml of blood within a month.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp